Metagenomi TherapeuticsMGX
13F holders, Q3 2025 (September 30)58holders −11
9new positions
18sold out
2famous investors
$2.36avg. 13F price*
At the end of Q3 2025, 58 institutions reported holding Metagenomi Therapeutics Inc. (MGX) in their 13F filings, down 11 from Q2 2025. 9 opened new positions and 18 sold out. The largest holders were Vanguard Group Inc. ($2.9M), Sozo Ventures GP II, L.P. ($1.3M) and Catalio Capital Management, LP ($1.3M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Metagenomi Therapeutics Inc.
- CUSIP
- 59102M104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $544K |
| Exits | 18 | $854K |
All 13F filers, Q2 2025 → Q3 2025: 673,993 shares bought and 1,923,974 shares sold, net −1,249,981 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 58 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.3% | 1,241,510 | $2.9M |
| Sozo Ventures GP II, L.P. | 100.00% | No change | 581,577 | $1.3M |
| Catalio Capital Management, LP | 0.23% | No change | 528,993 | $1.3M |
| Peapod Lane Capital LLC | 1.09% | Add +1.1% | 513,815 | $1.2M |
| Millennium Management | 0.00% | Reduce -18.9% | 310,692 | $736K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.5% | 291,890 | $692K |
| Pura Vida Investments, LLC | 3.82% | Reduce -72.2% | 264,391 | $627K |
| Morgan Stanley | 0.00% | Reduce -3.5% | 241,334 | $572K |
| BlackRock, Inc. | 0.00% | Reduce -24.6% | 223,451 | $530K |
| Two Sigma Investments, LP | 0.00% | Add +1394.4% | 207,528 | $492K |
| Bridgeway Capital Management, LLC | 0.01% | Add +98.4% | 195,800 | $464K |
| Renaissance Technologies | 0.00% | Add +40.3% | 167,000 | $396K |
| State Street Corp. | 0.00% | Reduce -7.1% | 121,537 | $288K |
| Wells Fargo & Company | 0.00% | Add +3.7% | 102,008 | $242K |
| Jane Street Group, LLC | 0.00% | Reduce -38.2% | 98,255 | $233K |
| Marshall Wace, LLP | 0.00% | Reduce -39.3% | 91,305 | $216K |
| Resolute Advisors LLC | 0.05% | No change | 89,944 | $213K |
| Walleye Capital LLC | 0.00% | New | 71,266 | $169K |
| RBF Capital, LLC | 0.01% | Reduce -11.5% | 70,780 | $168K |
| JPMorgan Chase & Co. | 0.00% | Add +4155.7% | 62,559 | $148K |
| BBR Partners, LLC | 0.01% | No change | 53,403 | $127K |
| Man Group plc | 0.00% | New | 52,888 | $125K |
| Two Sigma Advisers, LP | 0.00% | New | 50,400 | $119K |
| Northern Trust Corp. | 0.00% | Reduce -35.4% | 39,974 | $95K |
| Fortitude Advisory Group L.L.C. | 0.05% | Add +0.7% | 38,740 | $92K |
| Jacobs Levy Equity Management, Inc. | 0.00% | No change | 34,169 | $81K |
| Tang Capital Management LLC | 0.00% | Reduce -86.0% | 28,008 | $66K |
| Dynamic Technology Lab Private Ltd | 0.01% | New | 27,178 | $64K |
| UBS Group AG | 0.00% | Reduce -80.3% | 23,488 | $56K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +0.0% | 21,522 | $51K |
| Bank of America Corp. | 0.00% | Add +508.5% | 18,766 | $44K |
| XTX Topco Ltd | 0.00% | New | 15,216 | $36K |
| BNP Paribas Financial Markets | 0.00% | Add +1840.0% | 15,171 | $36K |
| Marex Group Ltd | 0.00% | No change | 15,000 | $35K |
| Green Alpha Advisors, LLC | 0.03% | Reduce -22.8% | 14,252 | $34K |
| HRT Financial LP | 0.00% | Reduce -76.1% | 14,097 | $33K |
| Two Sigma Securities, LLC | 0.00% | New | 12,189 | $29K |
| FMR LLC | 0.00% | Add +3.8% | 10,196 | $24K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +139.7% | 7,461 | $18K |
| Russell Investments Group, Ltd. | 0.00% | No change | 7,136 | $17K |
| Meeder Asset Management Inc. | 0.00% | No change | 5,496 | $13K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | Reduce -52.3% | 4,922 | $12K |
| US Bancorp \de | 0.00% | No change | 4,500 | $11K |
| Citigroup Inc. | 0.00% | Reduce -39.1% | 3,314 | $8K |
| Osaic Holdings, Inc. | 0.00% | Reduce -1.4% | 3,141 | $6K |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 610 | $1K |
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 593 | $1K |
| Principal Securities, Inc. | 0.00% | Reduce -71.9% | 544 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -18.6% | 511 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 500 | $1K |
| Royal Bank of Canada | 0.00% | New | 615 | $1K |
| Rialto Wealth Management, LLC | 0.00% | No change | 305 | $723 |
| Point72 (DIFC) Ltd | 0.00% | No change | 134 | $318 |
| Larson Financial Group LLC | 0.00% | Reduce -60.3% | 50 | $119 |
| Arax Advisory Partners | 0.00% | New | 30 | $71 |
| Optiver Holding B.V. | 0.00% | New | 18 | $43 |
| Barclays PLC | 0.00% | No change | 3 | $7 |
| Cwm, LLC | 0.00% | Reduce -98.0% | 33 | $0 |
"% of holder's portfolio" is MGX's weight in each manager's 13F, not the share of Metagenomi Therapeutics Inc. the manager owns.